Pascal Sienaert Selected Research

Dopa-responsive Dystonia

12/2009

Uneventful electroconvulsive therapy in a patient with dopa-responsive dystonia (Segawa syndrome).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Pascal Sienaert Research Topics

Disease

10	Bipolar Disorder (Manic Depressive Psychosis) 01/2022 - 06/2006
4	Mania (Manias) 01/2019 - 02/2013
3	Psychomotor Agitation (Akathisia) 01/2021 - 12/2004
2	Necrosis 01/2022 - 01/2019
2	Psychotic Disorders (Schizoaffective Disorder) 01/2021 - 11/2019
2	Major Depressive Disorder (Major Depressive Disorders) 05/2020 - 01/2019
2	Catatonia 03/2019 - 01/2014
2	Depressive Disorder (Melancholia) 01/2019 - 06/2016
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 06/2016 - 03/2013
2	Seizures (Absence Seizure) 06/2011 - 06/2004
1	Heart Arrest (Cardiac Arrest) 06/2022
1	Bradycardia 06/2022
1	Personality Disorders (Personality Disorder) 01/2022
1	Cognitive Dysfunction 11/2021
1	Atrophy 11/2021
1	Glioblastoma (Glioblastoma Multiforme) 03/2019
1	Inflammation (Inflammations) 01/2019
1	Drug-Induced Akathisia (Akathisia, Drug Induced) 01/2019
1	Dystonia (Limb Dystonia) 01/2019
1	Dyskinesias (Dyskinesia) 01/2019
1	Neuroleptic Malignant Syndrome 01/2019
1	Hepatic Encephalopathy 01/2019
1	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 01/2018
1	Treatment-Resistant Depressive Disorder 01/2016
1	Headache (Headaches) 01/2016
1	Nausea 01/2016
1	Dopa-responsive Dystonia 12/2009
1	Epilepsy (Aura) 06/2007
1	Tardive Dyskinesia 06/2005
1	Movement Disorders (Movement Disorder) 06/2005
1	Delirium 12/2004
1	Ehlers-Danlos Syndrome (Syndrome, Ehlers-Danlos) 12/2003

Drug/Important Bio-Agent (IBA)

3	Interleukin-6 (Interleukin 6)IBA 01/2022 - 01/2019
3	Antipsychotic Agents (Antipsychotics)IBA 01/2019 - 05/2012
2	Interleukin-10 (Interleukin 10)IBA 01/2022 - 01/2019
2	LithiumIBA 01/2021 - 11/2013
2	Antidepressive Agents (Antidepressants)IBA 05/2020 - 01/2019
2	Hydrocortisone (Cortisol)FDA LinkGeneric 11/2019 - 01/2019
2	Lorazepam (Ativan)FDA LinkGeneric 03/2019 - 01/2014
2	Methylphenidate (Ritalin)FDA LinkGeneric 01/2018 - 02/2013
2	Anticonvulsants (Antiepileptic Drugs)IBA 11/2013 - 06/2007
2	Lamotrigine (Lamictal)FDA LinkGeneric 06/2011 - 06/2007
1	C-Reactive ProteinIBA 01/2022
1	Pemetrexed (MTA)FDA Link 11/2021
1	Therapeutic UsesIBA 01/2020
1	BilirubinIBA 01/2019
1	Dopamine AntagonistsIBA 01/2019
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2019
1	Glutamic Acid (Glutamate)FDA Link 01/2019
1	Antimanic AgentsIBA 01/2018
1	Oxygen (Dioxygen)IBA 10/2017
1	Pharmaceutical PreparationsIBA 01/2017
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2017
1	IS 35IBA 06/2016
1	EsketamineIBA 01/2016
1	Tranylcypromine (Parnate)FDA LinkGeneric 12/2015
1	Glucose (Dextrose)FDA LinkGeneric 11/2015
1	Explosive Agents (Explosives)IBA 05/2015
1	BenzodiazepinesIBA 01/2014
1	Dopamine (Intropin)FDA LinkGeneric 12/2009
1	Guanosine Triphosphate (GTP)IBA 12/2009
1	Serotonin (5 Hydroxytryptamine)IBA 12/2009
1	Topiramate (Topamax)FDA LinkGeneric 06/2007
1	Gabapentin (Neurontin)FDA LinkGeneric 06/2007
1	Valproic Acid (Depakote)FDA LinkGeneric 06/2007
1	Carbamazepine (Tegretol)FDA LinkGeneric 06/2007
1	Dopamine Receptors (Dopamine Receptor)IBA 06/2005
1	Clozapine (Clozaril)FDA LinkGeneric 12/2004
1	Propofol (Diprivan)FDA LinkGeneric 12/2004
1	Remifentanil (Ultiva)FDA Link 06/2004
1	CollagenIBA 12/2003

Therapy/Procedure

3	Electrodes (Electrode) 06/2022 - 06/2016
2	Secondary Prevention 01/2021 - 01/2021
1	Chemoradiotherapy 03/2019
1	Therapeutics 06/2006
1	Anesthesia 06/2004